Administration of an anti-CC chemokine receptor 4 monoclonal antibody, mogamulizumab, before allogeneic bone marrow transplantation for adult T-cell leukemia/lymphoma.

Authors	S Haji, J Kiyasu, I Choi, Y Suehiro, K Toyoda, M Tsuda, A Takamatsu, Y Nakashima, H Miyoshi, M Shiratsuchi, S Yamasaki, N Uike, Y Abe
Journal	Bone marrow transplantation (Bone Marrow Transplant) Vol. 51 Issue 3 Pg. 432-4 (Mar 2016) ISSN: 1476-5365 [Electronic] England
PMID	26524267 (Publication Type: Case Reports, Letter)
Chemical References	Antibodies, Monoclonal, Humanized CCR4 protein, human Receptors, CCR4 mogamulizumab
Topics	Allografts Antibodies, Monoclonal, Humanized (administration & dosage) Bone Marrow Transplantation Female Humans Leukemia-Lymphoma, Adult T-Cell (therapy) Male Middle Aged Receptors, CCR4

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!